Diagnostic Health Services scores financing
Imaging services firm Diagnostic Health Services (DHS) this month secured a financing deal with UniCapital of Miami. As the Dallas firm’s primary lender, UniCapital has agreed to provide short-term financing to DHS to help the firm cover debt on
Imaging services firm Diagnostic Health Services (DHS) this month secured a financing deal with UniCapital of Miami. As the Dallas firms primary lender, UniCapital has agreed to provide short-term financing to DHS to help the firm cover debt on which it has defaulted. DHS remains in default of its senior credit agreements.
Also this month, Diagnostic Health Services hired a national consulting firm, Glass & Associates, which helps companies evaluate their restructuring, downsizing, strategic alliance, or sale options. The move comes after an attempt last year to merge with Medical Alliance collapsed after both companies boards of directors decided they couldnt deliver the anticipated value of the proposed deal to shareholders (SCAN 8/18/99). After the merger fell through, DHS focused on ways to improve its balance sheet by restructuring its senior and subordinated debt positions and began to seek options for raising capital. The companys stock was delisted from NASDAQ National Market on Aug. 11, and now trades on the Over the Counter bulletin board.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
